0

Xstrahl in action: Radiotherapy planning for Neuroblastoma investigation protocols

Neuroblastoma has one of the lowest survival rates of all childhood cancers despite the use of intensive treatment regimens usually consisting of a mix of surgery, chemotherapy, radiotherapy, [...]

0

Xstrahl In Action: SARRP used to develop an optimal craniospinal treatment plan for Medulloblastoma

At the 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO) researchers announced the development of an efficient and reproducible method to deliver craniospinal irradiation [...]

0

Xstrahl attended the 63rd Annual Meeting of the Radiation Research Society in Cancun (RADRES)

Xstrahl took part in the 63rd Annual Meeting of the Radiation Research Society held in Cancun, Mexico, on 15th to 18th October. The event, which gathered together most eminent professionals in [...]

0

Xstrahl in action: Improving relapse rates in Glioblastomas

Patients with glioblastoma have poor outcomes due to local relapse despite surgery and high-dose radiotherapy. Resistance to radiotherapy is thought to be due to efficiency of DNA repair cells, [...]